#vaccines

A STAT opinion feature on Amish views of vaccines and health care costs points to wider public health implications as the community’s population continues to grow.

Health secretary Robert F. Kennedy Jr. is seeking access to large pools of identifiable medical records as part of autism and vaccine research efforts, raising legal and privacy concerns.

A new Nature Medicine comment argues that HPV vaccination has become a core part of the global cancer agenda, even as major delivery and equity challenges remain.

A revised charter for the CDC’s vaccine advisory committee has been withdrawn after an administrative error, halting changes that critics said would have widened the path for anti-vaccine influence over federal policy.

Before vaccines, some parents intentionally exposed children to chickenpox to avoid worse infections later in life. That mindset has not entirely disappeared, even after vaccination changed the risk equation.

Researchers report an HIV vaccine design that steered immune responses toward a conserved region of the virus and produced broadly neutralizing antibodies in macaques.

Negotiators in Geneva have started an extra week of talks on the unresolved pathogen-sharing system at the heart of the pandemic treaty, with rich and developing countries still divided over access and benefits.

Doctors are seeing rotavirus infections earlier in the season than usual, but the effect of widespread vaccination remains clear: far fewer children are ending up in the hospital.

A STAT News newsletter item points to growth in an international childhood vaccine campaign at a moment when vaccine policy and public-health messaging remain under close watch.

The FDA is moving closer to naming a new leader for its Center for Biologics Evaluation and Research, according to Endpoints News, a decision with implications for vaccines and biologic regulation.

A newly published charter for the CDC’s vaccine advisory panel adds an explicit focus on vaccine safety after a judge suspended most Trump administration appointments to the committee.

A large trial in India found two new tuberculosis vaccines were safe in adults and children, but neither delivered broad protection against all forms of TB.

Federal health officials are changing eligibility rules for a key vaccine advisory panel after a judge ruled that many current members do not meet the required qualifications.

A new pediatric analysis spanning the 2021 to 2024 influenza seasons found that vaccine protection shifted from year to year but still reduced both hospitalizations and outpatient visits.

A new study suggests seasonal influenza vaccination may help prepare the immune system beyond the viruses targeted in a given year, adding a longer-view argument for routine immunization.

A long-stagnant field is moving again as tuberculosis drug and vaccine development reaches its broadest pipeline on record, raising the prospect of shorter treatments and the first new vaccine class in a century.

An intranasal vaccine administered without needles provided mice with broad protection against diverse respiratory bacteria and viruses, paving the way for human universal vaccine studies.

Scientists have developed DoriVac, a DNA nanostructure vaccine platform producing stronger and more durable immune responses than mRNA vaccines in early studies, with applications targeting HIV, Ebola, and COVID-19.

A growing body of research suggests that the shingles vaccine does more than prevent a painful rash — it may significantly reduce the risk of dementia, including Alzheimer's disease, and even slow biological aging. The latest studies add to evidence that has been accumulating for years.

With nearly 1,000 confirmed measles cases in 2026 spread across close to half of U.S. states, public health officials are sounding the alarm about a broader crisis. Declining vaccination rates could open the door to resurgences of mumps, hepatitis B, and other diseases once thought conquered.